Skip to content

Lateral Decubitus vs Traction in the Supine Position in Proximal Femoral Nailing. Is There a Huge Difference?

Proximal Femoral Nailing in Unstable Intertrochanteric Fractures: Lateral Decubitus Position Versus Supine Position on Traction Table.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07410338
Enrollment
77
Registered
2026-02-13
Start date
2024-06-30
Completion date
2025-07-30
Last updated
2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unstable Intertrochanteric Fracture

Keywords

Unstable intertrochanteric fracture, Proximal femoral nail, proximal femoral fractures, traction table, lateral decubitus

Brief summary

This study is designed to compare two positions in the management of unstable intertrochanteric femur fractures. It's to compare the traditional supine position using a traction table and lateral decubitus. This study is designed to Compare between The accuracy of reduction In both methods, in addition,the radiological exposure and other secondary outcomes, like the blood loss, are compared.

Detailed description

To compare the fluoroscopic exposure time, quality of radiographic reduction, intra operative blood loss, setup time and surgical time between the lateral decubitus position and the use of a traction table in supine position in fixation of unstable intertrochanteric femur fractures by proximal femoral nail.

Interventions

PROCEDURElateral decubitus postion during proximal femoral nailing for unstable intertrochnateric femur fractures

different positions of the patient during the surgery

PROCEDUREProximal femoral nailing for unstable intertrochnateric femur fractures in supine psoition using traction table

different positions for the proximal femoral nailing

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Skeletally mature patients * Unstable intertrochanteric fracture ( AO/OTA type 31A2 \& 31A3 )

Exclusion criteria

* Patients unfit for surgery * Revision cases * Patients with multiple or pathological, neglected or open fractures.

Design outcomes

Primary

MeasureTime frameDescription
Quality of radiographic reductionimmediate postoperativeOptimum Tip-to-apex distance (TAD) is 25mm or less. * Normal femoral neck shaft angle between 125 and 145 degree. * The Baumgartner reduction quality criteria : - 1. Criterion one (alignment) : 1. Anterior posterior view : normal or slight valgus neck shaft angle 2. lateral view : less than 20 degree of angulation (Slight valgus means a valgus of no more 10 degrees) 2. Criterion two (displacement) : 1. Anterior posterior view: less than 4 mm of displacement of any fragment. 2. Lateral view: less than 4 mm of displacement of any fragment. 3. The reduction will be categorized as good if both criteria were met, acceptable if only one criterion was met, and poor if Neither criterion was met.
Fluoroscopic exposure timeintraoperativeThe fluoroscopic exposure time is defined as: The total duration of fluoroscopy use in minutes during the set up and the surgical procedure.

Secondary

MeasureTime frameDescription
Setup timeIntraoperativeThe period between the moment of transfer of the patient from the anesthesia team to the surgical team till the time of incision. This period includes placement of the patient on the surgical table or the traction table, preparation, and draping. The reduction and use of fluoroscopy during the reduction will be included within this time frame.
Surgical timeIntraoperativeThe time between the skin incision and the closure of the wound.

Countries

Egypt

Contacts

STUDY_DIRECTORAmr Ahmed Abd Elrahman Hasan, Professor of Orthopedics

Department of Orthoepdics - Faculty of Medicine - Ain Shams University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026